ACCELERATOR INCUBATOR
OF FONDAZIONE GOLINELLI

THE PROJECTS SELECTED FOR "I-TECH INNOVATION 2022" WILL BE ANNOUNCED
IN OCTOBER 2022. MEANWHILE YOU CAN JOIN OUR NEXT INITIATIVES
SUBSCRIBING TO THE STARTHUB NEWSLETTER

2500+

hours of startup training provided

80+

mentors involved

3.500.000€

invested

22

startup accelerated

Roadmap

G-FACTOR

G-Factor is a reactive environment whose aim is to support new entrepreneurs and researchers with high entrepreneurial potential to become companies able to successfully establish themselves in the market, creating replicable and scalable models. Three years after its establishment, G-Factor has consolidated its position as an accelerator for start-ups in the life sciences sector, while opening up to other vertical sectors.

We invest in innovative start-ups and teams by providing capital and expertise because we believe that the mix of finance and training is crucial to entrepreneurial success.

Read moreMOSTRA MENO

I-Tech Innovation Program 2022 Download report 2021

I-Tech Innovation 2022 is the second edition of the program promoted by Fondazione Golinelli and CRIF. The project is based on 3 Calls for Innovation in the Life Science & Digital Health, FinTech & InsurTech and AgriTech & FoodTech segments. Besides, this year’s edition adds 2 Calls for Plug In in two disruptive areas Industry 4.0, Big Data processing-HPC & Applied Artificial Intelligence (in partnership with Competence Center Bi-Rex) and Social Impact (in partnership with Emil Banca e Gruppo BCC ICCREA).

Subscriptions to the call are open to researchers, independent teams, and startups who want to turn their projects into efficient business models and entities. The selected teams will be granted access to G-Force 2022, the acceleration customized program that offers investments, mentoring meetings and business networking opportunities.

This year’s investment consists of 1.500.000 €, that will be divided among the 16 startups’ batch composed of:

G-FORCE

G-Factor's acceleration program renews its formula in a tailored way, aimed to the I-Tech Innovation Program 2022 startups. Its teams will have access to an innovative acceleration program for young talents that will allow them to grow both in an entrepreneurial and scientific way. G-Force consists of 4 months: the first 2 months are based on intensive activities, which at least two residential weeks are part of. The selected teams will learn how to engage potential industrial partners. This first phase will be followed by 2 months of remote follow-up mentoring activities dedicated to execution. The startups, thanks to tailored meetings and specific training, will learn how to introduce themselves to potential investors and take the following steps for growth and development. The residential activities will mainly take place at BOOM, the new innovation center promoted by CRIF, and also in the G-Factor incubator-accelerator at Opificio Golinelli.

SERVICES & FACILITIES

  • Access to a network of highly qualified mentors and partners
  • Access to a network of investors
  • Legal and patent support
  • Regulatory advice
  • Media Coverage & Communications

JOIN STARTHUB

StartHub is the new community promoted by Fondazione Golinelli and CRIF and dedicated to startups in the Life Science & Digital Health, Fintech & InsurTech and FoodTech & AgriTech sectors.

Subscribing to the StartHub newsletter will grant you access to updates, training webinars, workshops and networking events that will encourage the crosspollination between the startups’ ecosystem and an international network of experts and players from the business, finance and research world.

Read moreShow less
Join Us

Upcoming G-Factor Events

image
GRATUITO
Wednesday 12 Oct 2022 ore 16:00
La community di StartHub riparte dopo la pausa estiva con un evento che ci darà finalmente la possibilità di incontrarci dal vivo, ma soprattutto che vi vede protagonisti. Vi aspettiamo il 12 ottobre a partire dalle 16 per pitchare di fronte a dei veri investitori!
Opificio Golinelli image

image Evento
image Impresa
See all

Network

We collaborate with dozens of entrepreneurs, teachers and managers with different specializations and professional backgrounds to cover all the needs of accelerated startups: from product development to business storytelling, from IP to negotiation, from hard skills to soft skills.

Our industrial partners are important international players in the world of life sciences operating in different business areas: from pharmaceutical to medical devices, from biotech to data science. Together with our industrial partners we help startups to create sustainable and scalable businesses.

Our network is enriched by the presence of research centers, startups, companies and universities that make innovation their daily mission.

We work together with some of the main Italian institutions to accompany our startups on their growth path.

Startups

124 applications have been received for the first call of G-Factor, Life Sciences Innovation : 30 of these have reached the final stage and 10 have been selected to participate in the acceleration process which has end in December 2019 with the awaited Investor Day. Each Startup has received an investment of €100,000 €

medtech

BCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.

medtech

Adam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled

bioengineering

Complexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.

medtech

Diamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.

bioengineering

eVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.

medtech

Genoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.

medtech

Holey has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.

medtech

MgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.

medtech

P4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.

medtech

RELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.

137 applications have been received for the second call of G-Factor, Life Sciences Innovation 2020: 24 of these have reached the final stage and 5 have been selected to participate in the acceleration process which will end in December 2020 with the awaited Investor Day. Each Startup will receive an investment of €125,000 of which € 90,000 of liquidity and € 35,000 in kinds.

nutraceutica

Thanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.

medtech

Innovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.

medtech

An innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.

pharma

Micro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.

medtech

RECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.

209 applications received for the I-Tech Innovation Program call launched by Fondazione Golinelli and CRIF in three areas: Life Sciences/Digital Health (3 startups selected), Fintech/Insurtech (2 startups selected), and FoodTech/Agritech (2 startups selected). 1 million euros has been invested for the startups

Lifescience/Digital health

created with the aim of experimenting a new compound called DDC#1 on humans for Acute Myeloid Leukemia and COVID-19 fighting

Lifescience/Digital health

goes to market through a device that makes the medicines’ selection process faster and more effective through the laboratory plastic creation of an environment that looks like the tissues of the human body and indeed similar to the context in which the medicine will work

Lifescience/Digital health

is based on the use of polymeric retinal prostheses for vision recovery, subsequent to a loss due to retinal degeneration induced by several diseases (i.e. retinitis pigmentosa).

Fintech/Insurtech

EvenFi is the crowdlending platform that offers investors the opportunity to earn by investing in growth projects of startups and SMEs.

Fintech/Insurtech

allows consumers to choose and select the innovative financial services that best comply with their needs. Its services let suppliers access a single distribution channel that guarantees them to contain acquisition costs.

Foodtech/Agritech

is the first virtual agricultural community based on two pillars: small producers and final consumers. It is also a marketplace for direct sales of agricultural products.

Foodtech/Agritech

is a unified data analysis platform that is fully automated and able to extract information from satellite images. By removing the technological barriers in the use of satellite data, the platform allows to transform satellite images into geospatial information by offering data the farmer needs in the simplest way to read them.

medtech

BCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.

medtech

Adam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled

bioengineering

Complexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.

medtech

Diamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.

bioengineering

eVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.

medtech

Genoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.

medtech

Holey has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.

medtech

MgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.

medtech

P4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.

medtech

RELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.

nutraceutica

Thanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.

medtech

Innovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.

medtech

An innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.

pharma

Micro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.

medtech

RECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.

lifescience

created with the aim of experimenting a new compound called DDC#1 on humans for Acute Myeloid Leukemia and COVID-19 fighting

lifescience

goes to market through a device that makes the medicines’ selection process faster and more effective through the laboratory plastic creation of an environment that looks like the tissues of the human body and indeed similar to the context in which the medicine will work

lifescience

is based on the use of polymeric retinal prostheses for vision recovery, subsequent to a loss due to retinal degeneration induced by several diseases (i.e. retinitis pigmentosa).

fintech

EvenFi is the crowdlending platform that offers investors the opportunity to earn by investing in growth projects of startups and SMEs.

fintech

allows consumers to choose and select the innovative financial services that best comply with their needs. Its services let suppliers access a single distribution channel that guarantees them to contain acquisition costs.

agritech

is the first virtual agricultural community based on two pillars: small producers and final consumers. It is also a marketplace for direct sales of agricultural products.

agritech

is a unified data analysis platform that is fully automated and able to extract information from satellite images. By removing the technological barriers in the use of satellite data, the platform allows to transform satellite images into geospatial information by offering data the farmer needs in the simplest way to read them.

Team

Antonio Danieli

Vice President, General Manager and Board Member
@ Fondazione Golinelli
CEO @ G-Factor Incubator-Accelerator

Federica Tadini

GM General manager

f.tadini@fondazionegolinelli.it
Benedetta D’Oria

CFO Chief Financial Officer

b.doria@fondazionegolinelli.it
Vanessa Claudia Mazzei

PM Project leader

vc.mazzei@fondazionegolinelli.it
Christian Lussafi

Analyst

c.lussafi@fondazionegolinelli.it
Silvia Cozzi

Program manager

s.cozzi@fondazionegolinelli.it
Giulia Mastandrea

Junior program manager

g.mastandrea@fondazionegolinelli.it
Francesco Castellana

Media manager

f.castellana@fondazionegolinelli.it

BUSINESS AND SCIENTIFIC REFEREES

Antonio Falcone

Independent Mentor

Raffaella Spagnuolo

Resident Scientific Referee

Gianluca Sferrazza

Independent Scientific Referee

Ilan Misano

Independent Scientific Referee

Emanuele Panza

Independent Scientific Referee

Francesco Lescai

Independent Scientific Referee

Giulia Falcone

Independent Business Referee

Carlo Tassi

Independent Business Referee

Emanuele D’Erme

Independent Mentor

Follow us

Contact Us

How can we help you?